Nielsen TO - Search Results

1

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.

Endo M, de Graaff MA, Ingram DR, Lim S, Lev DC, Briaire-de Bruijn IH, Somaiah N, Bovée JV, Lazar AJ, Nielsen TO. Endo M, et al. Among authors: nielsen to. Mod Pathol. 2015 Apr;28(4):587-95. doi: 10.1038/modpathol.2014.155. Epub 2014 Nov 21. Mod Pathol. 2015. PMID: 25412843 Free article.

2

Molecular characterisation of soft tissue tumours: a gene expression study.

Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M. Nielsen TO, et al. Lancet. 2002 Apr 13;359(9314):1301-7. doi: 10.1016/S0140-6736(02)08270-3. Lancet. 2002. PMID: 11965276

3

Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.

Hsu FD, Nielsen TO, Alkushi A, Dupuis B, Huntsman D, Liu CL, van de Rijn M, Gilks CB. Hsu FD, et al. Among authors: nielsen to. Mod Pathol. 2002 Dec;15(12):1374-80. doi: 10.1097/01.MP.0000039571.02827.CE. Mod Pathol. 2002. PMID: 12481020

4

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.

Nielsen TO, Hsu FD, O'Connell JX, Gilks CB, Sorensen PH, Linn S, West RB, Liu CL, Botstein D, Brown PO, van de Rijn M. Nielsen TO, et al. Am J Pathol. 2003 Oct;163(4):1449-56. doi: 10.1016/S0002-9440(10)63502-X. Am J Pathol. 2003. PMID: 14507652 Free PMC article.

5

Nuclear beta-catenin in mesenchymal tumors.

Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, Hsu FD, West RB, Nielsen TO. Ng TL, et al. Among authors: nielsen to. Mod Pathol. 2005 Jan;18(1):68-74. doi: 10.1038/modpathol.3800272. Mod Pathol. 2005. PMID: 15375433 Free article.

6

The gene expression profile of extraskeletal myxoid chondrosarcoma.

Subramanian S, West RB, Marinelli RJ, Nielsen TO, Rubin BP, Goldblum JR, Patel RM, Zhu S, Montgomery K, Ng TL, Corless CL, Heinrich MC, van de Rijn M. Subramanian S, et al. Among authors: nielsen to. J Pathol. 2005 Aug;206(4):433-44. doi: 10.1002/path.1792. J Pathol. 2005. PMID: 15920699

7

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

Turbin DA, Cheang MC, Bajdik CD, Gelmon KA, Yorida E, De Luca A, Nielsen TO, Huntsman DG, Gilks CB. Turbin DA, et al. Among authors: nielsen to. Mod Pathol. 2006 Jan;19(1):69-74. doi: 10.1038/modpathol.3800484. Mod Pathol. 2006. PMID: 16258514 Free article.

8

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO. Terry J, et al. Among authors: nielsen to. Am J Surg Pathol. 2007 Feb;31(2):240-6. doi: 10.1097/01.pas.0000213330.71745.39. Am J Surg Pathol. 2007. PMID: 17255769

9

Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.

Lee CH, Espinosa I, Jensen KC, Subramanian S, Zhu SX, Varma S, Montgomery KD, Nielsen TO, van de Rijn M, West RB. Lee CH, et al. Among authors: nielsen to. Mod Pathol. 2008 May;21(5):531-9. doi: 10.1038/modpathol.3801023. Epub 2008 Jan 11. Mod Pathol. 2008. PMID: 18192965 Free article.

10

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.

Cheng H, Dodge J, Mehl E, Liu S, Poulin N, van de Rijn M, Nielsen TO. Cheng H, et al. Among authors: nielsen to. Hum Pathol. 2009 Sep;40(9):1244-51. doi: 10.1016/j.humpath.2009.01.011. Epub 2009 Apr 14. Hum Pathol. 2009. PMID: 19368956

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page